Skip to main content
Equibles

GUGGENHEIM CAPITAL LLC

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1283072 Chicago, IL
Back to RXRX Full portfolio

Position in RXRX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$899,336
+$141,949 QoQ
Shares Held
245,051
-0.7% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#78
of 344 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GUGGENHEIM CAPITAL LLC holds $211,944,812 across 76 Biotechnology names. RXRX ranks #50 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 115,233 $57,239,687
2 REGN
Regeneron Pharmaceuticals, Inc.
 45,969 $28,663,508
3 ALNY
Alnylam Pharmaceuticals, Inc.
 39,318 $11,835,897
4 INCY
Incyte Corp
 57,780 $6,549,940
5 RVMD
Revolution Medicines, Inc.
 26,474 $4,958,050
6 INSM
INSMED Inc
 38,766 $4,133,230
7 MRNA
Moderna, Inc.
 55,313 $3,873,568
8 BMRN
Biomarin Pharmaceutical Inc
 66,874 $3,826,530

All Filings in RXRX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $899,336 245,051
2026-03-31 $757,387 246,706
2025-12-31 $750,297 183,447
2025-09-30 $614,849 125,994
2025-06-30 $622,683 123,060
2025-03-31 $775,190 146,539
2024-12-31 $967,064 143,057
2024-09-30 $1,022,965 155,230
2024-06-30 $926,294 123,506
2024-03-31 $420,543 42,181
2023-12-31 $431,599 43,773
2023-09-30 $336,070 43,931
2023-06-30 $125,585 16,812